transplant rejection Oncocyte Switches Gears on Transplant Test Commercialization, Plans to Launch LDT Next Year Premium The company had previously planned to develop IVD kits for the US market but is now aiming to launch a lab-developed test in the second half of 2022. CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients The company is teaming up with the North American Pediatric Renal Trials and Collaborative Studies organization to study the long-term impact of AlloSure. Natera Aiming to Translate Success in Colorectal Cancer Diagnostics Into Other Areas Premium The company has signed a deal with Aarhus University that gives it access to a 40,000-sample biobank of patients who were screened for colorectal cancer. CareDx Works Toward Goal of Becoming Essential Transplant Diagnostics Company Premium The firm is aiming to create pan-organ transplant services that connect patients to doctors throughout the transplant and recovery process. CareDx Patents Deemed Invalid in Court Battle Against Natera, Eurofins Viracor In a separate case in which CareDx and Natera are suing each other for false advertising, a court has set a trial date in late October. Aug 11, 2021 Oncocyte Updates Plans for Chronix Transplant Tech; Will Develop and Market Kits in Europe Premium May 6, 2021 Natera Q1 Revenues Grow 62 Percent May 5, 2021 CareDx Q1 Revenues up 76 Percent Apr 28, 2021 NY State Department of Health Approves Eurofins Viracor Transplant Rejection Tests Mar 19, 2021 NephroSant Readies Launch of Kidney Transplant Rejection Assay Premium Mar 17, 2021 CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular Mar 16, 2021 NephroSant Raises $16M in Series A Funding Round Feb 26, 2021 GenDx HLA Genotyping Products Receives Health Canada IVD Approval Feb 25, 2021 CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring Premium Feb 24, 2021 CareDx Q4 Revenues Up 64 Percent Feb 8, 2021 Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test Feb 2, 2021 Devyser Diagnostics Raises $15.4M Through Private Placement Jan 27, 2021 Devyser Eyes Early Detection of Transplant Rejection With DNA Sequencing Tests Premium Jan 27, 2021 Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy Premium Jan 19, 2021 Devyser Receives €750K Grant to Build Sequencing Assay for Early Detection of Transplant Rejection Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 7, 2021 CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Oct 29, 2020 CareDx Q3 Revenues Up 58 Percent Oct 7, 2020 CareDx Preliminary Q3 Revenues Up 57 Percent Load More Breaking News Pediatric Cardiomyopathy Exome Sequencing Study Suggests More Disease Genes to be Found People in the News: New Appointments at Helix, Pacific Biosciences, SomaLogic, More New Products Posted to GenomeWeb: Amoy Diagnostics, Akoya Biosciences, Congenica, Lucence In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More Florida Lab Owner Pleads Guilty to $6.9M COVID-19 False Billing Scheme Pacific Biosciences Outlines Progress on Short-Read Sequencing at JPM, Partners With Canexia Health The Scan Close Panel Vote on Califf Nomination The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate. Task Force Reports on Scientific Integrity Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council. Across the Hall Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports. Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder In Science this week: genes regulating chromatin modification may contribute to OCD risk.